Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Operating Expenses | 4,715 | 10,510 | 3,953 |
| Operating Income | -4,715 | -10,510 | -3,953 |
| Interest Expense | 1,121 | 104 | 42 |
| Other Income | 292 | -276 | 20 |
| Pre-tax Income | -5,543 | -10,890 | -3,975 |
| Net Income Continuous | -5,543 | -10,890 | -3,975 |
| Minority Interests | 49 | 1,175 | 541 |
| Net Income | $-5,494 | $-9,715 | $-3,433 |
| EPS Basic Total Ops | -0.43 | -0.76 | -0.27 |
| EPS Basic Continuous Ops | -0.43 | -0.76 | -0.27 |
| EPS Diluted Total Ops | -0.43 | -0.76 | -0.27 |
| EPS Diluted Continuous Ops | -0.43 | -0.76 | -0.27 |
| EBITDA(a) | $-4,268 | $-10,694 | $-3,865 |